IndraLab

Statements


| 1

reach
"In a previous study, we have demonstrated that RL could inhibit the TAK1 and NF-kappaB, TAK1/AP-1, TBK1 and IRF3 pathways in LPS stimulated murine RAW 264.7 and human THP-1 cells."